Notice: Trying to get property 'slug' of non-object in /home/sgumdev/public_html/wp-content/themes/sgum_2016/single.php on line 44

written by reader The arts and crafts of trading.

By alanh, February 2, 2016

The KSS threads are primarily designed to identify, scientifically analyze and focus on the development of scientifically promising/ novel bio advances. It will inevitably take time for these to prove their worth; so any investment in the company/ticker developing these ’new’ drugs/devices should be considered as a ’long’ investment.
However, there are some among us that believe there are quicker profits to me made by timing their trades in and out more rapidly… certain cases, Im among them.
This thread aims to allow the ’trader’ minded people to share such info/theses without detracting from or cluttering the main bio threads.
Enjoy, but remember, its v speculative stuff and, in the end, only one person is responsible for the decision to invest or not….that’s the person who signs the cheque… YOU !

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.



This site uses Akismet to reduce spam. Learn how your comment data is processed.

Inline Feedbacks
View all comments
6 years ago

So this is general trading all stocks or just trading biotech/medtech stocks?

👍 236
6 years ago
Reply to  modernrock

As with all these blogs they become whatever the readers make them through their questions and comments. I note that no moderator is listed so perhaps one will arise to give some direction and preserve this effort. This is certainly an area where money can be made ,,,or lost ,,,rapidly, depending on timing and methods.

👍 7795
👍 4086
6 years ago

If i were Gambly1 i had to think three times at least to participate here!
I hope he will, but honestly Alan why should he?.. . Some of his posts were deleted on thew other thread, at least that what it looks like from here. Ihave his post on my email, but it does not appear anywhere on the thread. Anyway, I do not think Gamby1 to bew thinskinned, othewise he would not have stayed THAT LONG ON OTHE THREADS:. If anyone is to blame for Gambly1 not being here it is US. Hope I am wrong!

👍 170
👍 4086
Travis Johnson, Stock Gumshoe
Reply to  alanh

We have neither lost nor deleted any comments, nor do we ever delete comments because we find them annoying or less than thoroughly trustworthy or of the proper tone, I expect us all to be adults and make our own judgements — and preferably not rush to same. Dunno if Dr KSS has removed any comments lately, his opinions differ than mine and he can do as he wishes with his comment threads.

The error you encountered is unrelated, those discussions aren’t missing either, just a little redirect glitch on submission for new discussions.

Add a Topic
👍 15112
👍 4086
6 years ago
Reply to  alanh

Alan, this one is for you!
This is one of Gambly1’s comments that is not on the thread anymore! Travis clearly stated that there was and is not a problem with the website and that he did not delete it. I do trust Travis and still wonder where the Gambly1’s comments went.
Here we go:
There is a new comment on: Cyto Who?

Comment Link:

Author: gambly1

The next great trade that I told you about… was Sophiris (SPHS) before the P3 results on Nov 10. I posted my bullish comments on SPHS before the phase 3 results came out, and the reasons I was bullish.

For daring to post bullish comments on SPHS I was basically mocked and run off the board, accused of being a stock promoter and other unsavory insinuations. Yet I was proven right. My specific argument at the time (which turned out to be correct) was that the primary endpoint of the phase 3 trial was NOT a 2.0 point IPSS difference, as people believed, given that the interim endpoint was targeted at a 2.0 point IPSS difference, and that was why I believed the primary endpoint would be met.

I am going on the record, again, as saying that SPHS is going to partner with big pharma in the next few months and the stock price is going to hit 7-10$ in 2016. My specific argument this time is that there is a common misperception that PRX-302 needs to show a 2.0 point superiority to vehicle injection to be approved by FDA. I agree, that is the difference that needs to be shown for oral drugs, but those that follow SPHS understand that the vehicle (saline) injection itself causes a huge benefit in IPSS and as a result, IMO FDA is not going to require a 2.0 point IPSS improvement over vehicle injection, in order for PRX-302 to be approved. I am calling for a big pharma pa